Point72 Hong Kong’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,200
Closed -$3.64M 459
2022
Q3
$3.64M Buy
38,200
+26,400
+224% +$2.61M 0.13% 205
2022
Q2
$1.09M Buy
11,800
+4,100
+53% +$400K 0.04% 503
2022
Q1
$779K Sell
7,700
-69,100
-90% -$7.26M 0.03% 591
2021
Q4
$7.92M Buy
76,800
+32,600
+74% +$3.01M 0.27% 54
2021
Q3
$3.75M Buy
44,200
+30,800
+230% +$2.58M 0.12% 208
2021
Q2
$1.12M Sell
13,400
-26,900
-67% -$2.2M 0.04% 670
2021
Q1
$3.03M Sell
40,300
-7,300
-15% -$532K 0.1% 270
2020
Q4
$3.25M Buy
+47,600
New +$3.1M 0.15% 156

Other funds holding CVS

Point72 Hong Kong's CVS Position: Q1 2025 in Review

Point72 Hong Kong sold out of CVS Health (CVS) in Q1 2025, closing a stake of 71,234 shares — an estimated $3.2M sold.

Point72 Hong Kong first reported a position in CVS in Q4 2015 and held it in 18 quarters. The position peaked at $15M in Q2 2022. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Point72 Hong Kong reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 71,234 CVS Health shares in Q1 2025, an estimated $3.2M.
  • Point72 Hong Kong first reported a position in CVS Health in Q4 2015 and held it in 18 quarters.
  • Point72 Hong Kong's CVS Health position peaked at $15M in Q2 2022.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.